Selected research
Industry Growth & Trends
Global Fully MagLev Ventricular Assist Device (VAD) Industry Growth and Trends Forecast to 2032
Market perspective
The global Fully MagLev Ventricular Assist Device (VAD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fully MagLev Ventricular Assist Device (VAD) include BiVACOR, Shenzhen Core Medical Technology, Suzhou Tongxin Medical Devices and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Fully MagLev Ventricular Assist Device (VAD) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Fully MagLev Ventricular Assist Device (VAD) market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fully MagLev Ventricular Assist Device (VAD) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fully MagLev Ventricular Assist Device (VAD).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Fully MagLev Ventricular Assist Device (VAD) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Fully MagLev Ventricular Assist Device (VAD) Market by Company
BiVACOR
Shenzhen Core Medical Technology
Suzhou Tongxin Medical Devices
Abbott
Fully MagLev Ventricular Assist Device (VAD) Segment by Type
Left Ventricular Assist Device (LVAD)
Biventricular Assist Device (BiVAD)
Fully MagLev Ventricular Assist Device (VAD) Segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Fully MagLev Ventricular Assist Device (VAD) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fully MagLev Ventricular Assist Device (VAD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fully MagLev Ventricular Assist Device (VAD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fully MagLev Ventricular Assist Device (VAD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fully MagLev Ventricular Assist Device (VAD) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Fully MagLev Ventricular Assist Device (VAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Left Ventricular Assist Device (LVAD)
- Biventricular Assist Device (BiVAD)
Applications
- Bridge-to-transplant (BTT)
- Destination Therapy (DT)
- Others
Companies covered
- BiVACOR
- Shenzhen Core Medical Technology
- Suzhou Tongxin Medical Devices
- Abbott
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Estimates and Forecasts (2021-2032)
- 1.3 Fully MagLev Ventricular Assist Device (VAD) Market by Type
- 1.3.1 Left Ventricular Assist Device (LVAD)
- 1.3.2 Biventricular Assist Device (BiVAD)
- 1.4 Global Fully MagLev Ventricular Assist Device (VAD) Market Size by Type
- 1.4.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Fully MagLev Ventricular Assist Device (VAD) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Fully MagLev Ventricular Assist Device (VAD) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Fully MagLev Ventricular Assist Device (VAD) Industry Trends
- 2.2 Fully MagLev Ventricular Assist Device (VAD) Industry Drivers
- 2.3 Fully MagLev Ventricular Assist Device (VAD) Industry Opportunities and Challenges
- 2.4 Fully MagLev Ventricular Assist Device (VAD) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Fully MagLev Ventricular Assist Device (VAD) Revenue (2021-2026)
- 3.2 Global Top Players by Fully MagLev Ventricular Assist Device (VAD) Sales (2021-2026)
- 3.3 Global Top Players by Fully MagLev Ventricular Assist Device (VAD) Price (2021-2026)
- 3.4 Global Fully MagLev Ventricular Assist Device (VAD) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fully MagLev Ventricular Assist Device (VAD) Major Company Production Sites & Headquarters
- 3.6 Global Fully MagLev Ventricular Assist Device (VAD) Company, Product Type & Application
- 3.7 Global Fully MagLev Ventricular Assist Device (VAD) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fully MagLev Ventricular Assist Device (VAD) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fully MagLev Ventricular Assist Device (VAD) Players Market Share by Revenue in 2025
- 3.8.3 2025 Fully MagLev Ventricular Assist Device (VAD) Tier 1, Tier 2, and Tier 3
4 Fully MagLev Ventricular Assist Device (VAD) Regional Status and Outlook
- 4.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Fully MagLev Ventricular Assist Device (VAD) Historic Market Size by Region
- 4.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales in Value by Region (2021-2026)
- 4.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Fully MagLev Ventricular Assist Device (VAD) Forecasted Market Size by Region
- 4.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales in Value by Region (2027-2032)
- 4.3.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fully MagLev Ventricular Assist Device (VAD) by Application
- 5.1 Fully MagLev Ventricular Assist Device (VAD) Market by Application
- 5.1.1 Bridge-to-transplant (BTT)
- 5.1.2 Destination Therapy (DT)
- 5.1.3 Others
- 5.2 Global Fully MagLev Ventricular Assist Device (VAD) Market Size by Application
- 5.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 BiVACOR
- 6.1.1 BiVACOR Company Information
- 6.1.2 BiVACOR Business Overview
- 6.1.3 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 6.1.5 BiVACOR Recent Developments
- 6.2 Shenzhen Core Medical Technology
- 6.2.1 Shenzhen Core Medical Technology Company Information
- 6.2.2 Shenzhen Core Medical Technology Business Overview
- 6.2.3 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 6.2.5 Shenzhen Core Medical Technology Recent Developments
- 6.3 Suzhou Tongxin Medical Devices
- 6.3.1 Suzhou Tongxin Medical Devices Company Information
- 6.3.2 Suzhou Tongxin Medical Devices Business Overview
- 6.3.3 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 6.3.5 Suzhou Tongxin Medical Devices Recent Developments
- 6.4 Abbott
- 6.4.1 Abbott Company Information
- 6.4.2 Abbott Business Overview
- 6.4.3 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Abbott Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 6.4.5 Abbott Recent Developments
7 North America by Country
- 7.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales by Country
- 7.1.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2026)
- 7.1.3 North America Fully MagLev Ventricular Assist Device (VAD) Sales Forecast by Country (2027-2032)
- 7.2 North America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
- 7.2.1 North America Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country (2021-2026)
- 7.2.3 North America Fully MagLev Ventricular Assist Device (VAD) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Fully MagLev Ventricular Assist Device (VAD) Sales by Country
- 8.1.1 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2026)
- 8.1.3 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Forecast by Country (2027-2032)
- 8.2 Europe Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
- 8.2.1 Europe Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Fully MagLev Ventricular Assist Device (VAD) Market Size by Country (2021-2026)
- 8.2.3 Europe Fully MagLev Ventricular Assist Device (VAD) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales by Country
- 9.1.1 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
- 9.2.1 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Fully MagLev Ventricular Assist Device (VAD) Sales by Country
- 10.1.1 South America Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2026)
- 10.1.3 South America Fully MagLev Ventricular Assist Device (VAD) Sales Forecast by Country (2027-2032)
- 10.2 South America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
- 10.2.1 South America Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country (2021-2026)
- 10.2.3 South America Fully MagLev Ventricular Assist Device (VAD) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales by Country
- 11.1.1 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
- 11.2.1 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Fully MagLev Ventricular Assist Device (VAD) Value Chain Analysis
- 12.1.1 Fully MagLev Ventricular Assist Device (VAD) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Fully MagLev Ventricular Assist Device (VAD) Production Mode & Process
- 12.2 Fully MagLev Ventricular Assist Device (VAD) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Fully MagLev Ventricular Assist Device (VAD) Distributors
- 12.2.3 Fully MagLev Ventricular Assist Device (VAD) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst